Drug-Induced Anaphylaxis: An Update on Epidemiology and Risk Factors

被引:41
|
作者
Regateiro, Frederico S. [1 ,2 ,3 ]
Marques, Maria Luis [4 ]
Gomes, Eva Rebelo [4 ]
机构
[1] Ctr Hosp & Univ Coimbra, Allergy & Clin Immunol Unit, Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Inst Immunol, Coimbra, Portugal
[3] Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, Coimbra, Portugal
[4] Ctr Hosp & Univ Porto, Allergy & Clin Immunol Dept, P-3000075 Porto, Portugal
关键词
Drug-induced anaphylaxis; Drug allergy; Epidemiology; Risk factors; HYPERSENSITIVITY REACTIONS; FATAL ANAPHYLAXIS; UNITED-STATES; ALLERGY; HOSPITALIZATIONS; PREVALENCE; GUIDELINES; AMERICA;
D O I
10.1159/000507445
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Drug hypersensitivity is one of the most frequent causes of anaphylaxis, particularly in adults and in hospitalized patients. Drug-induced anaphylaxis (DIA) is also associated with more severe outcomes than other anaphylaxis triggers, and drugs are responsible for the majority of deaths due to anaphylaxis. We here review the current knowledge on the incidence, prevalence, drugs involved, mortality, and mortality risk factors for DIA. The incidence of both anaphylaxis and DIA seems to be increasing worldwide. Antibiotics and analgesics are the most frequently reported triggers of DIA. However, the importance of other drug groups should be taken into account, especially in particular settings (e.g., peri-operative and oncology). The identification of risk factors, geographical variables, and drugs associated with higher risk for DIA may improve the outcomes of this entity.
引用
收藏
页码:481 / 487
页数:7
相关论文
共 50 条
  • [1] Evaluation of the Potential Risk Factors for Drug-Induced Anaphylaxis in Adult Patients
    Demir, Semra
    Erdenen, Fusun
    Gelincik, Asli
    Unal, Derya
    Olgac, Muge
    Coskun, Raif
    Colakoglu, Bahauddin
    Buyukozturk, Suna
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 178 (02) : 167 - 176
  • [2] Risk factors of anaphylaxis in Korea: Identifying drug-induced anaphylaxis culprits using big data
    Ahn, Kyung-Min
    Kim, Byung-Keun
    Yang, Min-Suk
    MEDICINE, 2022, 101 (35) : E30224
  • [3] Drug-induced anaphylaxis
    Treudler, R.
    Claus, S.
    Simon, J. C.
    ALLERGOLOGIE, 2014, 37 (07) : 275 - 282
  • [4] Epidemiology of drug-induced anaphylaxis in a tertiary hospital in Korea
    Park, Han-Ki
    Kang, Min-Gyu
    Yang, Min-Suk
    Jung, Jae-Woo
    Cho, Sang-Heon
    Kang, Hye-Ryun
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (04) : 557 - 562
  • [5] Drug-Induced Anaphylaxis in Children
    Bianchi, Annamaria
    Valluzzi, Rocco
    Crisafulli, Giuseppe
    Bottau, Paolo
    Caimmi, Silvia
    Franceschini, Fabrizio
    Liotti, Lucia
    Mori, Francesca
    Riscassi, Sara
    Saretta, Francesca
    Scavone, Sara
    Caffarelli, Carlo
    BIOMEDICINES, 2024, 12 (03)
  • [6] Drug-Induced Anaphylaxis
    Aun, Marcelo Vivolo
    Kalil, Jorge
    Giavina-Bianchi, Pedro
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2017, 37 (04) : 629 - +
  • [7] Epidemiology and Risk Factors for Idiosyncratic Drug-Induced Liver Injury
    Bjornsson, Einar S.
    SEMINARS IN LIVER DISEASE, 2014, 34 (02) : 115 - 122
  • [8] Drug-induced anaphylaxis: is it an epidemic?
    Giavina-Bianchi, Pedro
    Aun, Marcelo V.
    Kalil, Jorge
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 18 (01) : 59 - 65
  • [9] Drug-Induced Anaphylaxis in Latin American Countries
    Jose Jares, Edgardo
    Baena-Cagnani, Carlos E.
    Sanchez-Borges, Mario
    Ensina, Luis Felipe C.
    Arias-Cruz, Alfredo
    Gomez, Maximiliano
    Noemi Cuello, Mabel
    Maria Morfin-Maciel, Blanca
    De Falco, Alicia
    Barayazarra, Susana
    Bernstein, Jonathan A.
    Serrano, Carlos
    Monsell, Silvana
    Schuhl, Juan
    Cardona-Villa, Ricardo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2015, 3 (05): : 780 - 787
  • [10] Drug-induced Anaphylaxis
    Labella, Marina
    Maria, Rocio Saenz de Santa
    Bogas, Gador
    Salas, Maria
    Fernandez, Tahia D.
    Mayorga, Cristobalina
    Torres, Maria Jose
    Dona, Inmaculada
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (03) : 196 - 208